Continued from page 1

She said the company wanted to be transparent to “avoid a situation similar to the one a competitor found themselves in a while back,” referring to a report by the Daily Press newspaper in Virginia in 2005 about the hiring by BioPort Corp., another competitor, of a former HHS official as a consultant.

In a May 11 earnings conference call, Mr. Fuerst said he became interested in joining the company for two reasons.

“First, because I felt that I could be more effective in helping to advance these critical biodefense products by transferring the skills and knowledge I had cultivated within government service to industry,” he said.

“And second, because I believe very much in the merits of PharmAthene’s portfolio, its operational team and the need to see these products commercialized,” he added.